Alzheimer's disease and estrogen replacement therapy - where are we now?

References

• Evans DA. Estimated prevalence of Alzheimer’s disease in the United States. Milbank Q 1990; 68: 267–89.
   Google Scholar
• Skoog I, Nilsson L, Palmertz B, Andreasson L-A, Svanborg A. A population-based study of dementia in 85 yearolds. N Engl J Med 1993; 328: 153–8.
   Google Scholar
• Paganini-Hill A. Alzheimer’s disease in women: can estrogen play a protective role. Menopause Rew 2000; 4: 68–76.
   Google Scholar
• Jorm AF, Korten AE, Henderson AS. The prevalence of dementia: a quantitative integration of the literature. Acta Psychiatr Scand 1987; 76: 465–79.
   Google Scholar
• Lantos PL, Cairns NJ. The neuropathology of Alzheimer’s disease. In: Burns A, Levy R, (eds.): Dementia. London: Chapman and Hall, 1994: 185–207.
   Google Scholar
• Masters CL, Simms G, Weinman NA et al. Amyloid plaque core protein in Alzheimer’s disease and Down syndrome. Proc Natl Acad Sci 1985; 82: 4245–9.
   Google Scholar
• Skoog I, Gustafson D. HRT and dementia. J Epidemiol Biostatist 1999; 4: 227–52.
   Google Scholar
• Sherwin BB. Estrogen and/or androgen replacement therapy and cognitive functioning in surgically menopausal women. Psychoneuroendocrinology 1988; 13: 345–57.
   Google Scholar
• Resnick SM, Maki PM, Golski S, Kraut MA, Zonderman AB. Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance. Horm Behav 1998; 34: 171–82.
   Google Scholar
• Shaywitz SE, Shaywitz BA, Pugh KR et al. Effect of estrogen on brain activation patterns in postmenopausal women during working memory tasks. JAMA 1999; 281: 1197–202.
   Google Scholar
• Polo-Kantola P, Portin R, Polo O, Helenius H, Irjala K, Erkkola R. The effect of short-term estrogen replacement therapy on cognition: a randomized, double-blind, crossover trial in postmenopausal women. Obstet Gynecol 1998; 91: 459–66.
   Google Scholar
• Paganini-Hill A, Henderson VW. Estrogen deficiency and risk of Alzheimer’s disease in women. Am J Epidemiol 1994; 140: 256–61.
   Google Scholar
• Tang M-X, Jacobs D, Stern Y et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer’s disease. Lancet 1996; 348: 429–32.
   Google Scholar
• McEwen BS, Alves SE. Estrogen actions in the central nervous system. Endocrin Rev 1999; 20: 279–307.
   Google Scholar
• Luine VN. Estradiol increases choline acetyltransferase activity in specific basal forebrain nuclei and projection areas of female rats. Exp Neurol 1985; 89: 484–90.
   Google Scholar
• Frankfurt M, McKittrick CR, Menderson SD, McEwen BS. Effect of 5,7-dihydroxytryptamine, ovariectomy and gonadal steroids on serotonin receptor binding in rat brain. Neuroendocrinology 1994; 59: 245–50.
   Google Scholar
• Kritzer MF, Kohama SG. Ovarian hormones differentially influence immunoreactivity for dopamine betahydroxylase, choline acetyltransferase, and serotonin in the dorsolateral prefrontal cortex of adult rhesus monkeys. J Comp Neurol 1999; 409: 438–51.
   Google Scholar
• Di Paolo T. Modulation of brain dopamine transmission by sex steroids. Rev Neurosci 1994; 5: 27–41.
   Google Scholar
• Luine VN, Richards ST, Wu VY, Beck KD. Estradiol enhances learning and memory in a spatial memory task and effects levels of monoaminergic neurotransmitters. Horm Behav 1998; 34: 149–62.
   Google Scholar
• Hidalgo A, Barami K, Iversen K, Goldman SA. Estrogens and non-estrogenic ovarian influences combine to promote the recruitment and decrease the turnover of new neurons in the adult female canary brain. J Neurobiol 1995; 27: 470–87.
   Google Scholar
• Pike CJ. Estrogen modulates neuronal bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer’s disease. J Neurochem 1999; 72: 1552–63.
   Google Scholar
• Gangar KF, Vyas S, Whitehead M, Crook D, Meire H, Campbell S. Pulsatility index in internal carotid artery in relation to transdermal oestradiol and time since menopause. Lancet 1991; 338: 839–42.
   Google Scholar
• Fillit H, Weinreb H, Cholst I et al. Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer’s type. Psychoneuroendocrinology 1986; 11: 337–45.
   Google Scholar
• Honjo H, Ogino Y, Naitoh K et al. In vivo effects by estrone sulfate on the central nervous system-senile dementia (Alzheimer’s type). J Steroid Biochem 1989; 34: 521–5.
   Google Scholar
• Ohkura T, Isse K, Akazawa K et al. Evaluation of estrogen treatment in female patients with dementia of the Alzheimer’s type. Endocr J 1994; 41: 361–71.
   Google Scholar
• Honjo H, Ogino Y, Naitoh K et al. An effect of conjugated estrogen to cognitive impairment in women with senile dementia-Alzheimer’s type: a placebo-controlled double blind study. J Jpn Menopause Soc 1993; 1: 167–71.
   Google Scholar
• Yaffe K, Sawaya G, Lieberburg I, Grady D. Estrogen therapy in postmenopausal women. Effects on cognitive function and dementia. JAMA 1998; 279: 688–95.
   Google Scholar
• Mulnard RA, Cotman CW, Kawas C et al. for the Alzheimer’s Disease Cooperative Study. Estrogen replacement therapy for treatment of mild to moderate Alzheimer Disease. A randomized controlled trial. JAMA 2000; 283: 1007–15.
   Google Scholar
• Ylikorkala O. Balancing between observational studies and randomized trials in prevention of coronary heart disease by estrogen replacement. HERS study was no revolution. Acta Obstet Gynecol Scand 2000; 79: 1029–36.
   Google Scholar
• Naessen T. The Heart and Estrogen/Progestin Replacement Study (HERS) in perspective – Results not surprising. Acta Obstet Gynecol Scand 2000; 79: 1037–41.
   Google Scholar
• Henderson VW, Paganini-Hill A, Miller BL et al. Estrogen for Alzheimer’s disease in women: randomized, doubleblind, placebo-controlled trial. Neurology 2000; 54: 295–301.
   Google Scholar
• Schneider LS, Farlow MR, Henderson VW, Pogoda JM. Effects of estrogen replacement therapy on response to tacrine in patients with Alzheimer’s disease. Neurology 1996; 46: 1580–4.
   Google Scholar
• Laine K, Palovaara S, Tapanainen P, Manninen P Plasma tacrine concentrations are significantly increased by concomitant hormone replacement therapy. Clin Pharmacol Ther 1999; 66: 602–8.
   Google Scholar
• Waring SC, Rocca WA, Petersen RC et al. Postmenopausal estrogen replacement therapy and risk of AD: a population-based study. Neurology 1999; 52: 965–70.
   Google Scholar